←Back to Expert Scholars
Translational Medicine / 转化医学Advanced Breast Cancer Clinical Trials
Hope Rugo
MD
🏢University of California San Francisco🌐USA
Professor of Medicine
110
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Hope Rugo has led pivotal metastatic breast cancer trials of CDK4/6 inhibitors, antibody drug conjugates, and sacituzumab govitecan. Her work shapes global standards in hormone receptor-positive and triple negative metastatic disease. She continues to lead trials at UCSF.
Share:
🧪Research Fields 研究领域
metastatic breast cancer
CDK4/6 inhibitors
antibody drug conjugates
endocrine therapy
HER2-low disease
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Hope Rugo 的研究动态
Follow Hope Rugo's research updates
留下邮箱，当我们发布与 Hope Rugo（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment